Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Biopharma
Sort By
Newest First
1 / 4
1 / 4
Financing
Samsung Biologics reports third quarter 2024 financial results
Samsung Biologics
PR-10-24-NI-58
Oct 23, 2024
Biopharma
Life Sciences and Cryoport Form Partnership to Elevate Standards for Frozen Egg, Embryo, etc Offsite Storage and Biologistics
Cryoport
PR-10-24-NI-52
Oct 21, 2024
FDA
FDA Approves IMULDOSA, Accord BioPharma's Biosimilar to STELARA, for the Treatment of Chronic Inflammatory Conditions
Accord Biopharma
PR-10-24-NI-43
Oct 14, 2024
Appointment
Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024
Prime Therapeutics
PR-10-24-NI-40
Oct 11, 2024
Biopharma
AbZelectPRO™ enables biopharma customers to reach their research cell bank in 10 weeks with 8g/L
Abzena
PR-09-24-NI-18
Sep 26, 2024
Biotech
Five Small Biotechs to Watch: October 2024
David Alvaro, Ph.D.
Pharma's Almanac
PR-09-24-NI-10
Sep 23, 2024
Sustainability
Piramal Pharma’s GHG Commitment Validated and Approved by SBTi
Piramal Pharma Ltd.
PR-09-24-NI-04
Sep 16, 2024
Female-Centric
Transforming Drug Development through a Female Perspective
Chia Chia Sun; William Freimuth, Ph.D., M.D.
Fab Biopharma
PAO-09-24-CL-03
Sep 10, 2024
Monoclonal Antibodies
Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies
Coriolis Pharma
PR-05-24-NI-02
Jun 18, 2024
Protein Degradation
PROTACS: Upgrading Small Molecule Inhibitors
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-24-NI-02
Jun 11, 2024
CDMO - Small Biotech
Cis-Targeted Immunotherapies Need Large CDMO Expertise But Also Flexibility
Julie Trulson, Ph.D.
PAO-02-24-CL-07
Feb 15, 2024
Tech Transfer
Transparent Communication Supports Tech Transfers Of Cis-targeted Immunotherapies
Julie Trulson, Ph.D.
PAO-02-24-CL-06
Feb 15, 2024
Synthetic DNA
Is Synthetic Plasmid DNA One of the Solutions for Meeting Growing Demand for Next-Gen Therapies?
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-24-NI-04
Feb 06, 2024
Retinal Disease
Pioneering Breakthroughs in Retinal Disease Treatment
David Alvaro, Ph.D.; David Zacks, M.D., Ph.D.; David Esposito
Pharma's Almanac
PAO-12-23-CL-01
Dec 14, 2023
Supply Chain
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
Tim Tyson; Jesse McCool, Ph.D.; Russell Harris; Yongkwan Ma
TriRx Pharmaceutical Services
PTV-12-23-CL-02
Dec 12, 2023
CDMO Selection
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
Scorpius BioManufacturing
PAO-11-23-CL-04
Dec 08, 2023
CMC
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
Jesse McCool, Ph.D.; David Schmidt, M.B.A., M.Sc.; Oren Beske, Ph.D.; Stephen Monks, Ph.D.
Wheeler Bio
PAO-07-23-CL-05
Jul 26, 2023
Critical Cleaning
Aqueous Critical Cleaning for Pharma and Biopharma Applications (Companion to Aqueous Cleaning Handbook)
Michael Moussourakis
Alconox Inc.
PAO-04-23-CL-03
Apr 20, 2023
UN Global Compact
CDMO Joins United Nations Global Compact
Vetter Pharma International GmbH
PR-M03-23-02
Mar 08, 2023
Contamination Control Event
Ecolab and Pharma’s Almanac Present Contamination Control Event
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-022-CL-04
Nov 15, 2022
